Vicente E. S.
- Country
- Spain
- Department
- Reumatology
Research Overview
- A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
- Efficacy and Safety of Barzolvolimab in Patients with Chronic Spontaneous Urticaria Symptomatic Despite H1 Antihistamine Treatment: A Phase 3 Randomized, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 65 of 158 partner sites.
Specializations
Dermatological Research
The investigator specializes in the study and treatment of chronic spontaneous urticaria, focusing on innovative therapeutic approaches for patients with persistent hive conditions.
- Urticaria Management
- Novel Therapeutic Pathways
- Immunological Skin Disorders
Their research centers on evaluating new treatment options to reduce urticaria activity and improve patient outcomes in chronic urticaria conditions.
Immunological Studies
The investigator's work encompasses the investigation of immunological mechanisms underlying chronic urticaria, with particular attention to targeted therapeutic interventions.
- Immune Response Modulation
- Biological Therapy Assessment
- Clinical Immunology
Their expertise extends to understanding complex immune responses in chronic skin conditions and evaluating innovative treatment approaches.
Clinical Assessment
The investigator focuses on developing and implementing clinical evaluation methods for measuring treatment efficacy in chronic urticaria patients.
- Treatment Response Metrics
- Patient Outcome Assessment
- Clinical Scoring Systems
Their work involves utilizing standardized assessment tools including weekly urticaria activity scoring to evaluate therapeutic effectiveness.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.